Medi Assist Healthcare Services Ltd

The transcript does not explicitly mention specific figures or details regarding current or expected order book or pending orders for Medi Assist Healthcare Services Limited. However, relevant insights include: - Contract liabilities increased to INR 280.8 crores from INR 227 crores YoY, indicating improvement in new business acquired (Page 12). - There is ongoing migration and scaling up of insurer volumes on the MAtrix platform, with expectations to reach full volume across clients in the next 2-3 quarters (Pages 15-16). - Strong focus on expanding tech business revenues both in India and internationally, with significant interest in the HealthX platform for private medical insurance (Page 15). - Execution on Paramount integration, aiming for disciplined execution over the next 2-3 quarters to stabilize EBITDA margins (Page 18). No explicit pending orders or order book size is disclosed.

- The company has become debt-free as of January 2026, having repaid INR 39.4 crores of debt. - There is a strong balance sheet with free cash flow of INR 200 crores as of December 31, 2025. - Management emphasized no current requirement of finance charges going forward, indicating no immediate need for debt. - No explicit mention of any new fundraising plans through either debt or equity was made in the call or presentation. - The focus appears to be on capital allocation to technology initiatives and accelerating business integration using existing resources. - The management aims to judiciously deploy available capital to drive customer experience and growth rather than raising new funds currently.

- The company has become debt-free, providing capital availability to judiciously deploy in services to enhance customer experiences. - There is a strong focus on technology deployments, particularly on expanding the tech SaaS revenue model (e.g., MAtrix platform, MAven Guard, and other AI capabilities). - Investments are underway in digital infrastructure and tech platforms, including the technology transformation related to Star Health integration. - AI-led products and technology-driven services, such as fraud, waste and abuse detection (MAven Guard) and cashless experience improvement (Raksha Prime), are areas of strategic investment. - The structural integration of Paramount TPA business through Medi Assist TPA, effective from February 1, 2026, is expected to accelerate operational efficiencies and expansion. - Continued investment will focus on scaling up new tech solutions both in India and internationally, including international private medical insurance markets (HealthX initiative).

- Growth expected from ongoing migration of insurer volumes to the MAtrix platform, with full volume ramp-up anticipated in the next 2-3 quarters. - Retail premiums are expected to recover and grow post a 2-3 quarter typical reallocation cycle in PSU portfolios. - Expansion of technology-led revenue streams, especially from SaaS products like MAtrix and AI-driven solutions such as MAven Guard, with tech revenues growing 81.5% over 9 months and now making ~2.5% of total revenue. - Increasing market penetration with new insurer partnerships, both in India and internationally, including travel and private medical insurance segments. - Focus on outcome-based revenue models beyond transaction-based fees, particularly in fraud, waste, and abuse (FWA) detection and efficiency improvements in cashless services. - Growth driven by integration and acceleration of Paramount acquisition benefits and continued innovation in service and technology offerings.

- The company expects to improve core EBITDA margins over the next 2 to 3 quarters through disciplined execution and integration of Paramount (Page 18). - Tech revenues, currently about 2.5% of consolidated revenues, are anticipated to grow faster than the core business and be margin-accretive (Page 16). - Continued focus on capitalizing on ongoing tech projects in India and internationally, including the HealthX platform for international markets, aiming for meaningful revenue and margin contributions (Page 16). - Strong balance sheet and debt-free status provide capacity to invest in tech and accelerate growth opportunities (Page 18). - Reported 24% consolidated revenue growth in 9 months FY '26 indicates positive momentum (Page 6). - EBITDA margin improved by 154 bps quarter-on-quarter, with expected sustained margin expansion (Page 8). - Focus on AI-led offerings to drive operational efficiencies and P&L savings for insurer partners supports profitability growth (Page 6).